APC Mouse Anti-Human CD105 Antibody (S-837-10)

產(chǎn)品型號：S0B5195

更新時間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問量：57

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

神經(jīng)纖維絲輕鏈(NfL)單抗：助力神經(jīng)損傷診斷

還在為GFP蛋白純化煩惱？斯達(dá)特Anti-GFP讓你事半功倍

蛋白受體與疾病的關(guān)系詳細(xì)解析

促紅素：從生命密碼到醫(yī)療革命的全面解析

產(chǎn)品介紹

CD105, also known as endoglin, is a type I transmembrane glycoprotein predominantly expressed on endothelial cells and serves as an accessory receptor for the transforming growth factor-beta （TGF-β） superfamily. It plays a crucial role in angiogenesis, making it a key factor in tumor growth, survival, and metastasis. Structurally, CD105 is a homodimeric protein with a large extracellular domain, a hydrophobic transmembrane region, and a short cytoplasmic tail. Its expression is upregulated in proliferating endothelial cells, especially in tumor vessels, inflamed tissues, and during embryogenesis. Mutations in the CD105 gene are associated with hereditary hemorrhagic telangiectasia （HHT）, a disorder characterized by abnormal blood vessel formation. Due to its involvement in angiogenesis, CD105 has emerged as a potential therapeutic target for cancer treatment.

上一個：S0B5196APC Mouse Anti-Human CD134 Antibody (S-R589)